CN103494194B - 一种雄蜂参七胶囊及生产工艺 - Google Patents
一种雄蜂参七胶囊及生产工艺 Download PDFInfo
- Publication number
- CN103494194B CN103494194B CN201310443016.5A CN201310443016A CN103494194B CN 103494194 B CN103494194 B CN 103494194B CN 201310443016 A CN201310443016 A CN 201310443016A CN 103494194 B CN103494194 B CN 103494194B
- Authority
- CN
- China
- Prior art keywords
- parts
- ginseng
- powder
- drone
- pseudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 244000131316 Panax pseudoginseng Species 0.000 title claims abstract description 61
- 239000002775 capsule Substances 0.000 title claims abstract description 37
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 33
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 33
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 33
- 235000003181 Panax pseudoginseng Nutrition 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 238000005516 engineering process Methods 0.000 title claims abstract description 12
- 238000009472 formulation Methods 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 63
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 19
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 19
- 235000003222 Helianthus annuus Nutrition 0.000 claims abstract description 17
- 229940038481 bee pollen Drugs 0.000 claims abstract description 16
- 229920002472 Starch Polymers 0.000 claims abstract description 13
- 235000019698 starch Nutrition 0.000 claims abstract description 13
- 239000008107 starch Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 7
- 244000020551 Helianthus annuus Species 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims description 37
- 241001016310 Epimedium grandiflorum Species 0.000 claims description 30
- 235000018905 epimedium Nutrition 0.000 claims description 30
- 244000246386 Mentha pulegium Species 0.000 claims description 20
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 20
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 20
- 235000001050 hortel pimenta Nutrition 0.000 claims description 20
- 239000009874 shenqi Substances 0.000 claims description 18
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 230000003749 cleanliness Effects 0.000 claims description 3
- 238000007603 infrared drying Methods 0.000 claims description 3
- 238000007493 shaping process Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 4
- 230000006870 function Effects 0.000 abstract description 16
- 230000004060 metabolic process Effects 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 6
- 210000003169 central nervous system Anatomy 0.000 abstract description 5
- 230000010261 cell growth Effects 0.000 abstract description 4
- 230000002124 endocrine Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract description 2
- 239000002075 main ingredient Substances 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 52
- 241000208818 Helianthus Species 0.000 description 13
- 241000125175 Angelica Species 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- -1 flavone compound Chemical class 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000002929 anti-fatigue Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- HEVGGTGPGPKZHF-UHFFFAOYSA-N 1-(1,2-dimethyl-3-methylidenecyclopentyl)-4-methylbenzene Chemical compound CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- DFAAYQHTFVTATL-UHFFFAOYSA-N Isoeugenitin Chemical compound O1C(C)=CC(=O)C=2C1=C(C)C(OC)=CC=2O DFAAYQHTFVTATL-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- RGIBXDHONMXTLI-UHFFFAOYSA-N chavicol Chemical compound OC1=CC=C(CC=C)C=C1 RGIBXDHONMXTLI-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241001362411 Epimedium sagittatum Species 0.000 description 3
- XFYIHRTWDXNCTA-UHFFFAOYSA-N Eugenin Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC1CCC2C(C)(CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1C XFYIHRTWDXNCTA-UHFFFAOYSA-N 0.000 description 3
- 239000005770 Eugenol Substances 0.000 description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000012716 cod liver oil Nutrition 0.000 description 3
- 239000003026 cod liver oil Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- SUTUBQHKZRNZRA-UHFFFAOYSA-N eugenin Chemical compound O1C(C)=CC(=O)C=2C1=CC(OC)=CC=2O SUTUBQHKZRNZRA-UHFFFAOYSA-N 0.000 description 3
- 229960002217 eugenol Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 3
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 2
- VLXDPFLIRFYIME-QRTUWBSPSA-N (1S,2R,6R,7R,8S)-1,3-dimethyl-8-propan-2-yltricyclo[4.4.0.02,7]dec-3-ene Chemical compound C1C=C(C)[C@@H]2[C@@]3(C)CC[C@@H](C(C)C)[C@@H]2[C@H]31 VLXDPFLIRFYIME-QRTUWBSPSA-N 0.000 description 2
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 2
- ZYRBXTNFHYZHSK-UHFFFAOYSA-N 1-(2,4,6-Trimethoxyphenyl)-1,3-butanedione Chemical compound COC1=CC(OC)=C(C(=O)CC(C)=O)C(OC)=C1 ZYRBXTNFHYZHSK-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- XSSGQRFNGHRFBC-UHFFFAOYSA-N 5,7-dihydroxy-2,8-dimethyl-1-benzopyran-4-one Chemical compound C1=C(O)C(C)=C2OC(C)=CC(=O)C2=C1O XSSGQRFNGHRFBC-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- ZRGOVKQDBSFQIU-RDYCXQFPSA-N C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(C)=O)O3)O)[C@@H](OC(C)=O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(C)=O)O3)O)[C@@H](OC(C)=O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 ZRGOVKQDBSFQIU-RDYCXQFPSA-N 0.000 description 2
- IAZKGRRJAULWNS-UHFFFAOYSA-N Chavicol Natural products OC1=CC=C(CCC=C)C=C1 IAZKGRRJAULWNS-UHFFFAOYSA-N 0.000 description 2
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 2
- SLKPBCXNFNIJSV-HNNXBMFYSA-N Cuparene Chemical compound C1=CC(C)=CC=C1[C@@]1(C)C(C)(C)CCC1 SLKPBCXNFNIJSV-HNNXBMFYSA-N 0.000 description 2
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- NUPSHWCALHZGOV-UHFFFAOYSA-N Decyl acetate Chemical compound CCCCCCCCCCOC(C)=O NUPSHWCALHZGOV-UHFFFAOYSA-N 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001362421 Epimedium brevicornu Species 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- CVBNMWXECPZOLM-UHFFFAOYSA-N Rhamnetin Natural products COc1cc(O)c2C(=O)C(=C(Oc2c1)c3ccc(O)c(O)c3O)O CVBNMWXECPZOLM-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 2
- ZJSIKVDEOWWVEH-UHFFFAOYSA-N alpha-himachalene Chemical compound C=C1CCCC(C)(C)C2C1CCC(C)=C2 ZJSIKVDEOWWVEH-UHFFFAOYSA-N 0.000 description 2
- 229940088601 alpha-terpineol Drugs 0.000 description 2
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 229930006722 beta-pinene Natural products 0.000 description 2
- GJYKUZUTZNTBEC-UHFFFAOYSA-N beta-thujene Chemical compound CC1C=CC2(C(C)C)C1C2 GJYKUZUTZNTBEC-UHFFFAOYSA-N 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 239000008139 complexing agent Substances 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 229930187783 epimedoside Natural products 0.000 description 2
- RGTSAUBIQAKKLC-UHFFFAOYSA-N eugenitin Chemical compound O1C(C)=CC(=O)C2=C1C=C(OC)C(C)=C2O RGTSAUBIQAKKLC-UHFFFAOYSA-N 0.000 description 2
- STMCQKWQJHZTKS-UHFFFAOYSA-N eugenitin Natural products CC(=O)c1cc2OC(=CC(=O)c2c(O)c1C)C STMCQKWQJHZTKS-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000007887 hard shell capsule Substances 0.000 description 2
- 210000005096 hematological system Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- ZRGOVKQDBSFQIU-UHFFFAOYSA-N korepimedoside A Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(OC3C(C(O)C(O)C(COC(C)=O)O3)O)C(OC(C)=O)C(C)O2)O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 ZRGOVKQDBSFQIU-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229940095102 methyl benzoate Drugs 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- JGUZGNYPMHHYRK-UHFFFAOYSA-N rhamnetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 JGUZGNYPMHHYRK-UHFFFAOYSA-N 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- LFJQCDVYDGGFCH-JTQLQIEISA-N (+)-β-phellandrene Chemical compound CC(C)[C@@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-JTQLQIEISA-N 0.000 description 1
- LFJQCDVYDGGFCH-SNVBAGLBSA-N (+/-)-beta-Phellandrene Natural products CC(C)[C@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-SNVBAGLBSA-N 0.000 description 1
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- OQHYAWWVSDRHNZ-XQAXOBNUSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO OQHYAWWVSDRHNZ-XQAXOBNUSA-N 0.000 description 1
- ZHAURGPSJHBQEI-GNFSWKDMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO ZHAURGPSJHBQEI-GNFSWKDMSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 1
- GQVMHMFBVWSSPF-SOYUKNQTSA-N (4E,6E)-2,6-dimethylocta-2,4,6-triene Chemical compound C\C=C(/C)\C=C\C=C(C)C GQVMHMFBVWSSPF-SOYUKNQTSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- CPGCVOVWHCWVTP-LJAQVGFWSA-N (S)-nonacosan-10-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)CCCCCCCCC CPGCVOVWHCWVTP-LJAQVGFWSA-N 0.000 description 1
- WMBOCUXXNSOQHM-FLIBITNWSA-N (Z)-3-butylidenephthalide Chemical compound C1=CC=C2C(=C/CCC)/OC(=O)C2=C1 WMBOCUXXNSOQHM-FLIBITNWSA-N 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-LQSBFMDOSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-LQSBFMDOSA-N 0.000 description 1
- QNVRIHYSUZMSGM-LURJTMIESA-N 2-Hexanol Natural products CCCC[C@H](C)O QNVRIHYSUZMSGM-LURJTMIESA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 241000244188 Ascaris suum Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- SNMIMWYZCXBQQW-UHFFFAOYSA-N Bilobanol Natural products O1C(CC(C)C)=CC(C2CC(O)C(C)=CC2)=C1 SNMIMWYZCXBQQW-UHFFFAOYSA-N 0.000 description 1
- 241001252601 Blumea Species 0.000 description 1
- VBLPYMKXZXKBPO-RGMNGODLSA-N C(CCC)(=O)O.C(CC)N[C@@H](CCO)C(=O)O Chemical compound C(CCC)(=O)O.C(CC)N[C@@H](CCO)C(=O)O VBLPYMKXZXKBPO-RGMNGODLSA-N 0.000 description 1
- DBTKUGNCCKNCFN-UHFFFAOYSA-N CCCCCC(O)CC.CCCCCC(O)CC Chemical compound CCCCCC(O)CC.CCCCCC(O)CC DBTKUGNCCKNCFN-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 239000001689 FEMA 4674 Substances 0.000 description 1
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000006859 Jasminum officinale Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- POIRVLZGTSWEMG-UHFFFAOYSA-N Magnoflorin Natural products N1CCC2=CC(OC)=C(O)C3=C2C1CC1=CC=C(OC)C(O)=C13 POIRVLZGTSWEMG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000025844 Prostatic disease Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 229930192704 Sagittatin Natural products 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 229930182647 Trilobatin Natural products 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- LFJQCDVYDGGFCH-UHFFFAOYSA-N beta-phellandrene Natural products CC(C)C1CCC(=C)C=C1 LFJQCDVYDGGFCH-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- CPGCVOVWHCWVTP-UHFFFAOYSA-N celidoniol Natural products CCCCCCCCCCCCCCCCCCCC(O)CCCCCCCCC CPGCVOVWHCWVTP-UHFFFAOYSA-N 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- GQVMHMFBVWSSPF-UHFFFAOYSA-N cis-alloocimene Natural products CC=C(C)C=CC=C(C)C GQVMHMFBVWSSPF-UHFFFAOYSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- SLKPBCXNFNIJSV-UHFFFAOYSA-N cuparene Natural products C1=CC(C)=CC=C1C1(C)C(C)(C)CCC1 SLKPBCXNFNIJSV-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- WVRVMHCZDFFAFB-UHFFFAOYSA-N epsilon-Cuprenene Natural products C1=CC(C)=CCC1C1(C)C(C)(C)CCC1 WVRVMHCZDFFAFB-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- MDKYYFBRCUVEAN-UHFFFAOYSA-N icaritin-3-O-rhamnopyranoside Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(O)C(CCC(C)(C)O)=C2O1 MDKYYFBRCUVEAN-UHFFFAOYSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002428 insect molting hormone Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- 239000002949 juvenile hormone Substances 0.000 description 1
- 229930014550 juvenile hormone Natural products 0.000 description 1
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- SUTSVCLKBLJSPQ-UHFFFAOYSA-N luteolin 7-glucoside Natural products OC1C(O)C(O)C(CO)OC1C1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 SUTSVCLKBLJSPQ-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 150000002729 menthone derivatives Chemical class 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- WMBOCUXXNSOQHM-UHFFFAOYSA-N n-butylidenephthalide Natural products C1=CC=C2C(=CCCC)OC(=O)C2=C1 WMBOCUXXNSOQHM-UHFFFAOYSA-N 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000036279 refractory period Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 229930190691 sagittatoside Natural products 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 1
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种雄蜂参七胶囊及生产工艺。该胶囊的配方包括,以雄蜂蛹、向日葵蜂花粉和油菜蜂花粉组成的主料,以及以田七粉、当归粉、人参粉、淫羊藿粉、淀粉、丁香粉和薄荷精组成的辅料;其中,各组分按照重量份分别为:雄蜂蛹100份-110份、向日葵蜂花粉80份-100份、油菜蜂花粉80份-100份、田七粉10份-30份、当归粉10份-30份、人参粉10份-30份、淫羊藿粉10份-30份、淀粉50份-60份、丁香粉3份、薄荷精2份。本发明的雄蜂参七胶囊能增强人体新陈代谢、调节人体内分泌、促进新细胞生长、延缓衰老、调节中枢神经系统、起到抗疲劳、促进血管扩张、提高男性性功能以及增强人体免疫的功能。
Description
技术领域
本发明涉及一种蜂产品,更具体的说,特别涉及一种雄蜂参七胶囊及生产工艺。
背景技术
由于雄蜂蛹具有各种功效,其非常适合作为保健产品或药品的原料。
(1)雄蜂蛹:雄蜂蛹的成分因日龄和饲料来源不同,存在一定差异;经分析测试,以22日龄含营养物质最丰富,其主要成分:蛋白质20.3%、碳水化合物19.5%、微量元素0.5%、脂肪7.5%、灰分9.5%。雄蜂肾是含有高蛋白、低脂肪、多种维生素和微量元素的理想营养食物。而蜂蛹的营养价值不低于蜂花粉,尤其是维生素A的含量大大超过牛肉,蛋白质仅次于鱼肝油,而维生素D则超过鱼肝油10倍。它的功效和作用包括:a、雄蜂蛹富含多种营养物质,其中维生素A的含量大大超过牛肉,维生素D的含量超过鱼肝油数倍。医学证明,雄蜂蛹含有几丁多糖,有显著抗衰老和抗细胞突变的作用;b、22日龄雄蜂蛹有让男人保肾抗衰老,延缓男性衰老,提高身体免疫力,增强性功能十分有效;c、雄蜂蛹能增强人体免疫力,促进新陈代谢,提高细胞活性,调节神经系统,对体质虚弱、失眠健忘、肾虚阳痿、性功能低下以及延缓衰老、扶体轻身都有极其明显的食疗作用。此外,雄蜂蛹所含丰富的保幼激素和脱皮激素有抗癌作用;d、雄蜂蛹有很高的营养价值,常食用能使人精神焕发,皮肤亮泽,头发黑亮,显示出很好的养颜美容作用。
(2)向日葵蜂花粉:向日葵蜂花粉的成分包括硒含量高,花粉多糖含量高,酶类的种类和含量高,纤维素含量高,维生素B族含量高,所有营养素种类全、含量配比均衡;它的功效和作用包括:具有味甘、通经活络之效,常服能治愈肠胃疾病,对结肠炎甚有疗效,癌症病人抗癌防癌,儿童服用增强体质,减肥人群服用可以减肥。
(3)油菜花粉:油菜花粉的成分包括黄酮类化合物、绿原酸、三萜烯酸含量高,营养成分均衡;它的功效和作用包括:含黄酮类较高,有抗动脉粥样硬化、治疗静脉曲张性疡、降低胆固醇和抗辐射、防治心脑血管疾病的作用,并对便秘有特效。防治前列腺疾病。对治疗糖尿病、贫血、防癌抗癌等都有疗效。
(4)田七:田七主要含挥发性成分、皂苷、黄酮苷、氨基酸等,止血活性成分为三七氨酸;它的功效和作用包括:a、扩张血管,降低血压,改善微循环,增强血流量,预防和治疗心脑组织缺血、缺氧症;b、促进蛋白质、核糖核酸(RNA)、脱氧核糖核酸(DNA)合成,强身健体;c、促进血液细胞新陈代谢,平衡调节血液细胞;d、双向调节中枢神经,提高脑力,增强学习和记忆能力;e、增强机体免疫功能,抗肿瘤;f、止血、活血化瘀;g、保肝、抗炎;h、延缓衰老;i、双向调节血糖、降低血脂、胆固醇,抑制动脉硬化。
(5)当归:当归含有挥发油和非挥发性成分;而挥发油中的中性油成分有:亚丁基苯酞、β-蒎烯、α-蒎烯、莰烯、对聚伞花素、β-水芹烯、月桂烯、别罗勒烯、6-正丁基-环庚二烯-1,4,2-甲基-十二烷-5-酮、苯乙酮、β-甜没药烯、异草蒲烯、草蒲二烯、花侧柏烯、α-雪松烯、藁本内枉费、正丁基四氢化本埠内枉费、正丁基内酯、正丁烯内酯、正十二烷醇、佛手柑内酯等,以及含有其他成分,如:豆甾醇、谷甾醇、豆甾醇-D-葡萄糖甙、十四醇-1,钩吻萤光素等。此外,当归中还含有蔗糖、果糖、葡萄糖、维生素A、维生素B12、维生素E;17种氨基酸以及钠、钾、钙、镁等20余种无机元素。它的功效和作用包括:a、对子宫平滑肌的作用,其含有兴奋和抑制子宫平滑肌的两种成分,且具有调节子宫平滑肌收缩,解除痉挛而达到调经止痛功效;b、对心血管系统的作用:具有抗心律失常作用,其抗心律失常作用可能与降低心脏兴奋性、延长心肌不应期有关,降血脂及抗实验性动脉粥样硬化作用;c、对血液系统的作用:包括,①、当归一直被中医视为补血要药,用于贫血的治疗。曾有人认为,当归的补血作用可能与含维生素B12有关。也有研究表明,单味当归并不能显著地促进失血性贫血动物红细胞和血色素的恢复;②、当归及其阿魏酸钠有明显的抗血栓作用;③当归有极显著的生血作用;④、消炎杀菌作用:当归对体外痢疾、伤寒、副伤寒、大肠杆菌、白喉杆菌、霍乱弧菌及溶血性链球菌等均有抗菌作用;⑤、美容养颜:当归通常研粉使用,具有美容功效和医疗功效,性温,味甘辛,元素;用其敷脸可以起到促进血液循环的作用,而当归的水溶液有极强的抑制酪酸氨酸酶活性的作用,是对付黄褐、雀斑的“杀手锏”,能使皮肤细嫩、有光泽的功效。
(6)人参:人参根中含人参皂甙0.4%,少量挥发油;油中主要成分为人参烯0.072%。据报导从根中分离出皂甙类:人参皂甙A、B、C、D、E和F等。人参皂甙A为人参皂甙Rg1。人参皂甙B和C水解后产生人参三醇皂甙元,人参皂甙D、E和F水解后得20-表人参二醇皂甙元。又自乙醚提取物的低沸点部分分离出β-榄香烯。高沸点部分分离出人参炔醇。此外尚含有单糖类:葡萄糖、果糖、蔗糖,三种三糖:葡萄糖-果糖-果糖、三聚葡萄糖,葡萄糖-葡萄糖-果糖,人参酸(为软脂酸、硬脂酸及亚油酸的混和物),多种维生素(B1、B2、菸酸、菸酰胺、泛酸),多种氨基酸、胆碱、酶(麦芽糖酶、转化酶、酯酶),精胺及胆胺。人参的地上部分含黄酮类化合物,人称人参黄甙、三叶甙。它的功效和作用包括:a、人参对中枢神经系统具有兴奋作用。而大量时反而有抑制作用。能加强动物高级神经活动的兴奋和抑制过程,并能增强机体对一切非特异性刺激的适应能力,能减少疲劳感(人参的根、茎、叶均能延长小白鼠游泳的持续时间)。b、人参对心肌及血管有直接作用,一般在小剂量时兴奋,大剂量时抑制。c、加强机体对有害因素的抵抗力。d、对因肾上腺素引起的高血糖动物有降低血糖的作用;对糖尿病患者除能自觉改善症状外,还有轻微的降血糖作用,并与胰岛素有协同作用。e、能促进动物的性腺功能。f、在适当剂量,对家兔也能增加体重,使血浆白蛋白与球蛋白的比值上升。g、刺激造血器官,有改善贫血的作用。h、长期服用小量,可使网状内皮系统即能亢进;剂量过大,则呈相反作用。
(7)淫羊藿粉:淫羊藿粉主要含黄酮类化合物、木脂素、生物碱、挥发油等,淫羊藿等植物中含有植物甾醇(Phytosterol)、棕榈酸(Palmitic acid)、硬脂酸(Stearic acid)、油酸(Oleic acid)、亚油酸(Linoleic acid)、亚麻酸(Linolenic acid)、银杏醇(Bilobanol)、木兰碱(Magnoflorin)、葡萄糖(Glucose)、果糖(Fructose)、维生素E 等;淫羊藿的叶和茎中含淫羊藿甙(Icariin)、淫羊藿糖甙(Epimedoside)A、B、C、D、E;此外, 箭叶淫羊藿尚含异槲皮素(Iso- quercetin)、淫羊藿-3-O-α-鼠李糖甙(Icaritin- -3-O-α-rhamnoside)、金丝桃甙(Hyperin);箭叶淫羊藿甙(Sagittatoside)A、B、C;箭叶淫羊藿素(Sagittatin)A、B 等。它的功效和作用包括:a、 对性机能的影响淫羊藿能增强下丘脑-垂体-性腺轴及肾上腺皮质轴,胸腺轴等内分泌系统的分泌功能;b、抗衰老作用;由于淫羊藿多糖和淫羊藿甙对Ts细胞作用相反,因此,淫羊藿对机体免疫功能有双向调节作用;c、对心血管系统有扩张的作用;d、镇咳、祛痰和平喘作用;e、抗炎及抗病原微生物作用,对肺炎双球菌、流感嗜血杆菌有轻度抑制作用.1%浓度对人型结核杆菌有抑菌效力.淫羊藿煎剂在试管内对脊髓灰质炎病毒有显著的抑制作用,在药物与病毒接触1小时内, 即表现灭活作用,对其他肠道病毒亦有抑制作用;f、对血液系统的作用淫羊藿煎剂、淫羊藿多糖、淫羊藿粗黄酮均能促进血小板聚集,改善血流动力和血液流变的作用, 并能提高白细胞生成。
(8)丁香:含挥发油,主要含有丁香油酚(Eugenol)78~95%、乙酰丁香酚(acetyl eugenol)约3%、B-石竹烯(B-Caryophyllene),以及甲基戊基酮、水杨酸甲酯、胡椒酚(Chavicol)、a-衣兰烯(a-Ylangene)等。也有野生品种中不含丁香油酚(平常丁香油中含64~85%),而含丁香酮(Eugenone)和番樱桃素(Eugenin)。花中还含有三萜化合物如齐墩果酸(Oleanolicacid)、黄酮和对氧萘酮类鼠李素(Rham-netin)、山奈酚(Kaempferol)、番樱桃素、番樱桃素亭(Eugenitin)、异番樱桃素亭(Isoeugenitin)及去甲基化合物异番樱桃酚(IsoeugenitoI),它的功效和作用为:a、抗菌作用:对许兰氏黄癣菌、白色念珠菌等多种致病性真菌均有抑制作用,当浓度较高时对新型隐球菌也有抑制作用,对金黄色葡萄球菌及肺炎、痢疾(志贺氏)、大肠杆菌、结核杆菌、鼠疫杆菌、霍乱弧菌、炭疽杆菌、伤寒杆菌、白喉杆菌、变形杆菌、枯草杆菌等均有抑制作用;b、驱虫作用:可在体外对猪蛔虫有麻痹或杀死作用;c、健胃作用:丁香为芳香健胃剂,可缓解腹部气胀、增强消化能力、减轻恶心呕吐,治慢性消化不良、胃肠充气及子宫疝痛;d、止痛作用:牙痛时取丁香油(少量滴入)可清毒龋齿腔,破坏其神经,从而减轻牙痛;e、对代谢的影响:丁香热水提取物及水溶性组份具有代谢活化的抑制作用及代谢活化Trp-p-2的失活作用的双重作用;f、平喘作用:B-丁香烯在丁香挥发油中含量约5.4%,亦是菊科植物艾叶油中的平喘有效成分之一;g、增强机体耐缺氧和抗寒的能力。
(9)薄荷精:其成分薄荷鲜叶含油1%~1.46%,油中主要成分为左旋薄荷醇(menthol),含量62.3%~87.2%,还含左旋薄荷酮(menthone)、异薄荷酮(isomenthone),乙酸葵酯(decyl acetate),乙酸薄荷酯(menthyl acetate),苯甲酸甲酯(methylbenzoate),α-及β-蒎烯(pinene),β-侧柏烯(β-thu-jene),3-戊醇(3-pentol),2-已醇(2-hexanol),3-辛醇(3-octanol),右旋月桂烯(myrcene),柠檬烯(limonene)及桉叶素(cineole),α-松油醇(α-terpineol)等。又含黄酮类成分:异瑞福灵(iso-raifolin),木犀草素-7-葡萄糖甙(luteolin-7-glucoside),薄荷异黄酮甙(methoside);有机酸成分:迷迭香酸(lusmarinic acid),咖啡酸(caffeic acid);氯基酸成分:天冬氨酸(qsparti cacid),谷氨酸(glutamic acid),丝氨酸(alanine),天冬酰胺(asparagine),缬氨酸(valine),亮氨酸(leuine)和异亮氨酸(isoleucine),苯丙氨酸(phenylalanine),蛋氨酸(methionine),赖氨酸(lysine)。它的功效和作用包括:一是医药用途:a、刺激和抑制神经的作用:对皮肤瘙痒具有抗过敏和止痒作用,对神经痛和风湿关节痛具有明显的缓解和镇痛作用;b、消炎和抗菌的作用,薄荷产品对蚊虫叮咬皮肤有脱敏、消炎和抗菌的作用。对上呼吸道感染亦有明显的止咳、消炎和抑菌作用;对痔疮、肛裂有消肿止痛、消炎抗菌的作用;c、健胃和祛风的作用:能促进口腔流涎、增进食欲、增加胃粘膜的供血量,改进消化功能。有益于治疗食积不化,解除胃脘涨滞感觉。也可治疗呃逆和痉挛性胃痛;d、芳香和调味的作用:主要利用薄荷所特有的清凉润喉而芳香宜人的气味来掩饰和改善一些具有异味和难以吞服的药物的不适感。二是工业用途:a、食品添加剂:在一些食品、糕点、糖果、酒类、饮料中加入微量的薄荷香精,即具有明显的芳香宜人的清凉气味,能够促进消化、增进食欲;b、烟草矫味剂:烤烟时加入薄荷精,可以明显减弱烟草的辛辣刺激味,变得温和而高雅,适口感更强,更适合妇女和老人吸用;c、日化加香杀菌剂:家庭卫生用品中加入适量薄荷脑油,既收清凉芳香之功效,又有杀菌消毒之妙用。
经发明人检索,现有技术还没有包括上述各种原料的蜂产品。
发明内容
本发明的目的在于提供一种雄蜂参七胶囊及生产工艺,其可以使雄蜂参七胶囊产品具有增强人体新陈代谢、调节人体内分泌、促进新细胞生长、延缓衰老、调节中枢神经系统、抗疲劳、促进血管扩张、提高男性性功能以及增强人体免疫的功能。
为了解决以上提出的问题,本发明采用的技术方案为:一种雄蜂参七胶囊,该配方包括,以雄蜂蛹、向日葵蜂花粉和油菜蜂花粉组成的主料,以及以田七粉、当归粉、人参粉、淫羊藿粉、淀粉、丁香粉和薄荷精组成的辅料;其中,各组分按照重量份分别为:雄蜂蛹100份~110份、向日葵蜂花粉80份~100份、油菜蜂花粉80份~100份、田七粉10份~30份、当归粉10份~30份、人参粉10份~30份、淫羊藿粉10份~30份、淀粉50份~60份、丁香粉3份、薄荷精2份。
本发明还提供一种新型的雄蜂参七胶囊产品的生产工艺,其包括以下步骤:
第一步、雄蜂蛹粉的制作步骤,将雄蜂蛹置远红外干燥箱90℃温度中进行干燥,干燥时间为30分钟至50分钟,干燥后的雄蜂蛹,再置低温-80℃进行再次干燥后,用万能粉碎机粉碎,并用80目筛过筛,得到雄蜂蛹粉;
第二步、蜂花粉的加入步骤,将向日葵蜂花粉、油菜蜂花粉晒干后经过筛选和混合后用万能粉碎机粉碎,并用80目筛过筛,然后加入到第一步中的雄蜂蛹粉中,充分均匀混合;
第三步、田七粉、当归粉、人参粉、淫羊藿粉的加入步骤及混合料步骤:将田七、当归、人参、淫羊藿分别洗净、干燥、切片、粉碎后,经80目过筛,在温度≤25℃、湿度≤35%的无菌车间中,充分混合田七粉、当归粉、人参粉、淫羊藿粉,并将该混合物加入到第二步中产生的混合物中去进一步混合;
第四步、丁香粉、薄荷精和淀粉的加入步骤:将丁香晒干后放入烘箱90℃、1小时烘干再用万能粉碎机粉碎,用80目筛过筛后,按配方比例与薄荷、淀粉充分混合,并在上述无菌车间将该混合物加入到第三步中产生的混合物中进一步混合;
第五步、将第四步中获得的混合物填充胶囊壳制成胶囊。
根据本发明的一优选实施例:所述第五步具体为,在洁净度至少为B级,温度≤25℃,湿度≤35%之间的生产环境中,将第四步中获得的混合物再填充入经过溶胶、制坯、干燥、拔壳、截割、整理成型后的胶囊中,获得雄蜂参七胶囊产品。
根据本发明的一优选实施例:所述雄蜂参七胶囊产品的规格为为0~3号。
与现有技术相比,本发明的有益效果在于:1、充分利用雄蜂蛹增强男性保肾抗衰老、延缓男性衰老、促进新陈代谢、调节神经系统、提高男性功能的作用,与向日葵蜂花粉和油菜蜂花粉增强人体新陈代谢、调节人体内分泌、促进新细胞生长、延缓衰老的功能相互作用;2、在雄蜂蛹、向日葵蜂花粉和油菜蜂花粉中添加田七粉、当归粉、人参粉、淫羊藿粉,,使产品在田七、当归、人参、淫羊藿的共同作用下,对中枢神经系统具有调节作用,起到抗疲劳、促进血管扩张、提高男性性功能作用。而且田七、当归、人参、淫羊藿的加入量较少,能起到一定的辅助作用;3、在本产品配方中添加丁香粉、薄荷精,既能同蜂花粉一起起到增强人体免疫功能和抗疲劳作用,同时又能使产品中雄蜂蛹的特殊气味和蜂花粉的青涩感减轻,起到络合剂和掩蔽剂的作用,使该产品口感柔和、适口性强、吸收加快。
附图说明
图1. 为本发明的新型的雄蜂参七胶囊产品的生产工艺流程图。
具体实施方式
下面结合实施例及附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。
本实施例提供一种雄蜂参七胶囊,该配方包括,以雄蜂蛹、向日葵蜂花粉和油菜蜂花粉组成的主料,以及以田七粉、当归粉、人参粉、淫羊藿粉、淀粉、丁香粉和薄荷精组成的辅料;其中,各组分按照重量份分别为:雄蜂蛹100mg~110mg、向日葵蜂花粉80mg~100mg、油菜蜂花粉80mg~100mg、田七粉10mg~30mg、当归粉10mg~30mg、人参粉10 mg~30mg、淫羊藿粉10 mg~30mg、淀粉50 mg~60mg、丁香粉3 mg、薄荷精2mg。
再参阅图1所示,本实施例提供一种根据上面的配方制成新型的雄蜂参七胶囊产品的生产工艺:
第一步、雄蜂蛹粉的制作步骤:将雄蜂蛹整理后,置远红外干燥箱90℃温度中进行干燥,时间为30分钟至50分钟,干燥后的雄蜂蛹,再置低温-80℃中进行再次冷冻干燥后,用万能粉碎机粉碎,用80目筛过筛,得到雄蜂蛹粉;
第二步、蜂花粉的加入步骤:将配方中向日葵蜂花粉、油菜蜂花粉晒干后经过筛选和混合后用万能粉碎机粉碎,用80目筛过筛,得到80mg向日葵蜂花粉、80mg油菜蜂花粉的混合物,将此蜂花粉混合粉体加入到100mg雄蜂蛹粉中,充分均匀混合;
第三步、田七粉、当归粉、人参粉、淫羊藿粉的加入步骤及混合料步骤:将田七、当归、人参、淫羊藿分别洗净、干燥、切片、粉碎,经80目过筛后,在温度≤25℃、湿度≤35%的无菌车间中,充分混合10mg田七粉、10mg当归粉、10mg人参粉、10mg淫羊藿粉,并将该混合物加入到第二步中产生的混合物中去进一步混合;
第四步、丁香粉、薄荷精、淀粉的加入步骤和混合料步骤:将丁香晒干后放入烘箱90℃、1小时烘干再用万能粉碎机粉碎,用80目筛过筛后,在上述无菌车间中,充分混合3mg丁香粉、2mg薄荷精、50mg淀粉,并将该混合物加入到第三步中产生的混合物中进一步混合;
第五步、制造硬壳胶囊步骤:具体为,在洁净度至少为B级,温度≤25℃,湿度≤35%之间的生产环境中,采用机械自动化生产优等硬胶囊,经过溶胶、制坯、干燥、拔壳、截割、整理成型;其胶囊壳厚度为0.1mm、溶解温度37℃、溶解时间10min;
第六步、填充胶囊步骤:按特定产品选择胶囊规格(可以为0~3号),装入填充机斗中,进行填充启动。将上述第四步中混合物进行机械自动化填充进入空胶囊壳中,(可以反复调试和试填,以使填充过程稳定一致)。一般在填充过程中要求上述各粉料要有良好的流动性;
第七步、帽体套合、封口:用机械自动将帽、体套合后,用20%明胶、40%水、40%乙醇的混合液进行胶囊帽体外壳喷涂封口(若使用锁口外壳胶囊,自身封闭性能好,就不需要喷涂封口);
第八步、检验、装瓶、贴标。对填充好的以及帽体封口后的胶囊进行整理和检验,并清除和收集残粉;将经检验合格的胶囊产品装入不锈钢物料桶中,进行装瓶、贴标、入库(若不合格的胶囊则剔除,并将粉料集中,在无菌车间中重新填充胶囊体中)。
在生产过程中,全部生产工艺的卫生条件应该符合 GMP的要求,且生产区的空气洁净度为10万级。
通过上述分配方和工艺制作出来的雄蜂参七胶囊产品,其具有以下的优点和功能:1、充分利用雄蜂蛹增强男性保肾抗衰老、延缓男性衰老、促进新陈代谢、调节神经系统、提高男性功能的作用,与向日葵蜂花粉和油菜蜂花粉增强人体新陈代谢、调节人体内分泌、促进新细胞生长、延缓衰老的功能相互作用。2、在雄蜂蛹、向日葵蜂花粉和油菜蜂花粉中添加田七粉、当归粉、人参粉、淫羊藿粉,使产品在田七、当归、人参、淫羊藿的共同作用下,对中枢神经系统具有调节作用,起到抗疲劳、促进血管扩张、提高男性性功能作用。而且田七、当归、人参、淫羊藿粉的加入量适中,能起到一定的辅助作用。3、在本产品配方中添加丁香粉、薄荷精,既能同蜂花粉一起起到增强人体免疫功能和抗疲劳作用,同时又能使产品中雄蜂蛹的特殊气味和蜂花粉的青涩感减轻,起到络合剂和掩蔽剂的作用,使该产品口感柔和、适口性强、吸收加快。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (4)
1.一种雄蜂参七胶囊,其特征在于:该胶囊的配方包括,以雄蜂蛹、向日葵蜂花粉和油菜蜂花粉组成的主料,以及以田七粉、当归粉、人参粉、淫羊藿粉、淀粉、丁香粉和薄荷精组成的辅料;其中,各组分按照重量份分别为:
雄蜂蛹100份-110份、向日葵蜂花粉80份-100份、油菜蜂花粉80份-100份、田七粉10份-30份、当归粉10份-30份、人参粉10份-30份、淫羊藿粉10份-30份、淀粉50份-60份、丁香粉3份、薄荷精2份。
2.一种根据权利要求1所述的雄蜂参七胶囊的生产工艺,其特征在于:包括以下步骤,
第一步、雄蜂蛹粉的制作步骤,将雄蜂蛹置远红外干燥箱90℃温度中进行干燥,干燥时间为30分钟至50分钟,干燥后的雄蜂蛹,再置低温-80℃再次进行冷冻干燥后,用万能粉碎机粉碎,并用80目筛过筛,得到雄蜂蛹粉;
第二步、蜂花粉的加入步骤,将向日葵蜂花粉、油菜蜂花粉晒干后经过筛选和混合后用万能粉碎机粉碎,并用80目筛过筛,然后加入到第一步中的雄蜂蛹粉中,充分均匀混合;
第三步、田七粉、当归粉、人参粉、淫羊藿粉的加入步骤:将田七、当归、人参、淫羊藿分别洗净、干燥、切片、粉碎后,经80目过筛后,在温度≤25℃、湿度≤35%的无菌车间中,充分混合田七粉、当归粉、人参粉、淫羊藿粉,并将该混合物加入到第二步中产生的混合物中去进一步混合;
第四步、丁香粉、薄荷精、淀粉的加入步骤:将丁香晒干后放入烘箱90℃、1小时烘干再用万能粉碎机粉碎,用80目筛过筛后,按配方比例与薄荷、淀粉充分混合,并在上述无菌车间将该混合物加入到第三步中产生的混合物中进一步混合;
第五步、将第四步中获得的混合物填充胶囊壳制成胶囊。
3.根据权利要求2所述的雄蜂参七胶囊的生产工艺,其特征在于:所述第五步具体为,在洁净度至少为B级,温度≤25℃,湿度≤35%之间的生产环境中,将第四步中获得的混合物填充入经过溶胶、制坯、干燥、拔壳、截割、整理成型后的胶囊中,获得雄蜂参七胶囊产品。
4.根据权利要求2所述的雄蜂参七胶囊的生产工艺,其特征在于:所述雄蜂参七胶囊产品的规格为为0-3号。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310443016.5A CN103494194B (zh) | 2013-09-26 | 2013-09-26 | 一种雄蜂参七胶囊及生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310443016.5A CN103494194B (zh) | 2013-09-26 | 2013-09-26 | 一种雄蜂参七胶囊及生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103494194A CN103494194A (zh) | 2014-01-08 |
CN103494194B true CN103494194B (zh) | 2015-06-24 |
Family
ID=49859534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310443016.5A Expired - Fee Related CN103494194B (zh) | 2013-09-26 | 2013-09-26 | 一种雄蜂参七胶囊及生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103494194B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108850945A (zh) * | 2018-04-23 | 2018-11-23 | 深圳市炜鑫生物科技有限公司 | 一种抗氧化保健食品及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100309A (zh) * | 1993-09-18 | 1995-03-22 | 敖济康 | 雄蜂蛹制剂的配方、工艺和效用 |
CN1432370A (zh) * | 2003-02-14 | 2003-07-30 | 杭州天地保健品有限公司 | 一种能抑制前列腺增生的产品配方及工艺 |
CN1850169A (zh) * | 2006-03-02 | 2006-10-25 | 北京新世纪海仑医药科技有限公司 | 一种具有防治前列腺或其相关疾病作用的蜂花粉组合物 |
CN101152239A (zh) * | 2006-09-27 | 2008-04-02 | 上海水产大学 | 一种雄蜂蛹冻干粉冲剂及胶囊的制备工艺 |
-
2013
- 2013-09-26 CN CN201310443016.5A patent/CN103494194B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100309A (zh) * | 1993-09-18 | 1995-03-22 | 敖济康 | 雄蜂蛹制剂的配方、工艺和效用 |
CN1432370A (zh) * | 2003-02-14 | 2003-07-30 | 杭州天地保健品有限公司 | 一种能抑制前列腺增生的产品配方及工艺 |
CN1850169A (zh) * | 2006-03-02 | 2006-10-25 | 北京新世纪海仑医药科技有限公司 | 一种具有防治前列腺或其相关疾病作用的蜂花粉组合物 |
CN101152239A (zh) * | 2006-09-27 | 2008-04-02 | 上海水产大学 | 一种雄蜂蛹冻干粉冲剂及胶囊的制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN103494194A (zh) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
US6416795B1 (en) | Herbal extract composition for stress prevention and treatment | |
CN105380051B (zh) | 一种解酒护肝饮料及其制备方法 | |
CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
KR20090078662A (ko) | 칼슘 화합물을 주성분으로 한 천연 원료의 숙취 해소용조성물 및 이의 제조 방법 | |
JP2003192605A (ja) | リパーゼ阻害剤 | |
CN104351450A (zh) | 一种橘红润喉奶糖及其制备方法 | |
CN107019186A (zh) | 一种含蜂花粉的膳食营养补充剂 | |
CN104381557A (zh) | 一种牛大力糖果制作方法 | |
KR101826737B1 (ko) | 생약재 추출물을 유효성분으로 하는 근육틱 및 우울증 개선용 조성물 및 그의 제조방법 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN101406291B (zh) | 一种草本植物营养饮料及其制造方法 | |
CN103892475A (zh) | 保健文胸 | |
CN107156829A (zh) | 一种适用于肝病患者的全营养配方食品 | |
CN105876783A (zh) | 一种铁皮石斛花组合物及其制法和保肝解酒制品 | |
CN103494194B (zh) | 一种雄蜂参七胶囊及生产工艺 | |
CN102823700A (zh) | 一种复方茯苓黑大蒜夹心巧克力的制备方法 | |
CN105285288A (zh) | 一种辅助治疗咽喉炎的奶糖及其制备方法 | |
CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN113018398A (zh) | 一种抗疲劳保健品及其制备方法 | |
CN102138593A (zh) | 荷叶消脂健美茶的配方 | |
KR20170024689A (ko) | 한방재를 이용한 배변촉진용 또는 다이어트용 식품조성물 | |
Algethami et al. | Bee pollen: Clinical trials and patent applications. Nutrients. 2022, 14, 2858 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150624 Termination date: 20200926 |